Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man
Main Authors: | Hazlehurst, Jonathan M., Oprescu, Andrei I., Nikolaou, Nikolaos, Di Guida, Riccardo, Grinbergs, Annabel E. K., Davies, Nigel P., Flintham, Robert B., Armstrong, Matthew J., Taylor, Angela E., Hughes, Beverly A., Yu, Jinglei, Hodson, Leanne, Dunn, Warwick B., Tomlinson, Jeremy W. |
---|---|
Format: | Online |
Language: | English |
Published: |
Endocrine Society
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701851/ |
Similar Items
-
Optimizing human hepatocyte models for metabolic phenotype and function: effects of treatment with dimethyl sulfoxide (DMSO)
by: Nikolaou, Nikolaos, et al.
Published: (2016) -
5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes
by: Nasiri, Maryam, et al.
Published: (2015) -
Loss of 5α-Reductase Type 1 Accelerates the Development of Hepatic Steatosis but Protects Against Hepatocellular Carcinoma in Male Mice
by: Dowman, Joanna K., et al.
Published: (2013) -
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
by: Armstrong, Matthew J., et al.
Published: (2016) -
The Effect of Marine Derived n-3 Fatty Acids on Adipose Tissue Metabolism and Function
by: Todorčević, Marijana, et al.
Published: (2015)